Corvus Pharmaceuticals Inc(C17) News

Date	Title
Jan 13	Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis